Article Details

Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1 ...

Retrieved on: 2021-11-12 12:05:26

Tags for this article:

Click the tags to see associated articles and topics

Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1 .... View article details on HISWAI: https://forextv.com/top-news/corvus-pharmaceuticals-presents-updated-data-from-mupadolimab-anti-cd73-phase-1-1b-clinical-trial-at-the-2021-society-for-immunotherapy-of-cancer-sitc-annual-meeting/

Excerpt

Additional mupadolimab oncology program highlights from the SITC ... Ikena Oncology Presents Data at SITC 36th Annual Meeting Describing the ...

Article found on: forextv.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up